Managers / Q2 2025 · view latest →
Orion Investment Co
CIK 0002033920 · 7800 FORSYTH BLVD. SUITE 820, ST. LOUIS, MO, 63105 · 314-725-3800
Summary
Orion Investment Co reported $282M in U.S.-listed holdings across 70 positions for Q2 2025.
Its largest position, MSFT, represents 18.6% of the portfolio.
Compared with Q1 2025, the fund opened 4 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 97.0% · $274M
- Other · 1.2% · $3M
- ETP · 1.1% · $3M
- MLP · 0.5% · $1M
- ADR · 0.2% · $562,505
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Vanguard Index Fds | NEW | +5.7K | 5.7K | +$3M | $3M |
| EPDEnterprise Prods Partners L | NEW | +20.5K | 20.5K | +$636,387 | $636,387 |
| CATCaterpillar Inc | NEW | +575 | 575 | +$223,221 | $223,221 |
| ORCLOracle Corp | NEW | +995 | 995 | +$217,537 | $217,537 |
| EPCEdgewell Pers Care Co | SOLD OUT | −8.0K | 0 | −$249,680 | $0 |
| ENREnergizer Hldgs Inc New | SOLD OUT | −8.0K | 0 | −$239,360 | $0 |
| IOVAIovance Biotherapeutics Inc | ADDED | +1.16M | 2.34M | +$103,408 | $4M |
| NOWServicenow Inc | ADDED | +892 | 2.2K | +$1M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $315M | 69 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $328M | 68 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $315M | 70 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $282M | 70 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $245M | 68 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $251M | 65 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $257M | 66 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $251M | 64 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.